New York Assembly Bill A04198

New York 2025-2026 Regular Session

• Introduced: 1/31/25
• Refer: 1/31/25
• Refer: 1/7/26

Caption

Requires pharmacists to include lot numbers or unique identifying numbers on prescription containers.

Summary

This bill amends the New York Education Law to require pharmacists to include the lot number or other unique identifying number associated with the original manufactured lot of a prescription drug on the prescription container. The measure adds this requirement to existing labeling rules that already require identifying information such as the drug’s NDC number and, in some cases, the names and business locations of the manufacturer and distributor. In practical terms, the bill is aimed at improving traceability of prescription medications after dispensing. By placing lot-specific information on the container, the bill would make it easier to identify and track a particular batch of medication in the event of a recall, quality issue, or investigation involving a drug product. The bill takes effect immediately upon enactment.

Impact

The bill would amend section 6811-a of the Education Law, expanding the labeling obligations for pharmacists and prescription drug containers in New York. It would require pharmacies to add the unique lot identifier for the manufactured batch of the dispensed drug, affecting pharmacy dispensing practices, prescription labeling systems, and potentially manufacturer-distributor-pharmacy recordkeeping. The change would primarily affect pharmacists, pharmacies, and prescription drug supply-chain participants by adding a new compliance requirement tied to drug traceability and recall management.

Sentiment

Based on the bill text and available context, the measure appears to be a straightforward consumer-safety and medication-tracking proposal with no recorded committee debate or vote history in the provided materials. The absence of opposition or recorded discussion suggests the bill was presented as a technical labeling improvement rather than a controversial policy change. Overall sentiment cannot be measured from votes or transcripts, but the purpose of the bill indicates a generally protective, public-safety-oriented intent.

Contention

No specific points of contention are documented in the provided committee transcripts or voting history because none were supplied. Potential areas of concern, if raised, would likely involve the administrative burden on pharmacists, the feasibility of printing lot numbers on all prescription containers, and whether the requirement could create implementation costs for pharmacies or software vendors. However, no stakeholder positions or formal objections are recorded in the available materials.